RVL Pharmaceuticals plc Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-08-12: Reporting owner Athyrium Opportunities IV Acquisition 2 LP | Athyrium Opportunities Associates IV GP LLC | Ferrell Jeffrey | Athyrium Opportunities Associates IV Co-Invest LLC | Athyrium Opportunities Associates IV LP | Athyrium Opportunities IV Co-invest 2 LP | Athyrium Funds GP Holdings LLC; Form 3; Security Warrants; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-08-12 holding as of filing | Athyrium Opportunities IV Acquisition 2 LP | Athyrium Opportunities Associates IV GP LLC | Ferrell Jeffrey | Athyrium Opportunities Associates IV Co-Invest LLC | Athyrium Opportunities Associates IV LP | Athyrium Opportunities IV Co-invest 2 LP | Athyrium Funds GP Holdings LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrants Derivative · Indirect · See footnote | Holding | $3.10 exercise price | 2022-08-12 |